CUV 19 Dec 2025, 8:34 AM

CLINUVEL progresses Level II ADR upgrade, Nasdaq uplist

Clinuvel Pharmaceuticals Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in